Navigation Links
Massachusetts General Hospital Center Reignites Methods in Bioengineering Conference
Date:4/6/2011

BOSTON, April 6, 2011 /PRNewswire/ -- The Center for Engineering in Medicine (CEM) -- a bioengineering research institute at the Massachusetts General Hospital (MGH), a Harvard Teaching Hospital -- has announced it will reconvene its popular "Methods in Bioengineering" conference in conjunction with event organizer Horizon House Ltd.  The event, BioMethods Boston, will take place at Harvard Medical School on July 14-15, and expects to draw over 400 senior researchers from the Boston biotech community.

BioMethods Boston has confirmed program participation from Harvard, MIT, Boston University, Northeastern, WPI, and Tufts, plus top-tier pharma companies like Millipore, Life Technologies, and Genzyme, as well as major health centers like Mass General Hospital and Children's Hospital Boston.

BioMethods Boston’s agenda will include sessions on stem cell therapies, functional imaging, BioMEMS, nanotechnologies, and gene delivery. A call for posters has just been announced, and an automated interface for submissions, as well as the nearly-complete agenda, can be accessed at the event website (www.biomethodsboston.com). "This event is designed to give biomedical investigators from all fields a clear perspective on the most advanced technologies, techniques, and methodologies, and an opportunity for attendees to network with top researchers in the field," says Dr. Martin Yarmush, Director of the CEM.

Yarmush is joined on the program committee by Dr. Robert Langer of MIT, named by Forbes' magazine as one of the 25 most important people in biotechnology, as well as Dr. James Burns, SVP, Drug & Biomaterial R&D at Genzyme Corp., Dr. Donald Ingber, Director, Wyss Institute for Biologically Inspired Engineering at Harvard, Dr. Joachim Kohn, Director, New Jersey Center for Biomaterials at Rutgers, Dr. Mehmet Toner, Director, BioMEMS Resource Center at MGH, Dr. Kyongbum Lee, Department Chair, C
'/>"/>

SOURCE Horizon House Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Massachusetts General Hospitals Warren Triennial Prize to honor pioneers of cellular reprogramming
2. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
3. Boston Medical Center to receive $245,000 grant from Attorney General Martha Coakley
4. Entrust President and CEO Bill Conner Addresses Global Dignitaries During INTERPOL 79th General Assembly
5. General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience
6. Major moral decisions use general-purpose brain circuits to manage uncertainty
7. Mass. General researchers develop functional, transplantable rat liver grafts
8. Oil Refineries Announces Delay to Annual & Special General Meeting
9. American Society for Microbiology to host 110th general meeting in San Diego
10. Modern man found to be generally monogamous, moderately polygamous
11. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/29/2014)... as a consequence of chemotherapy will benefit from a ... technology that prevents hair loss. , The research is ... scalp cooling manufacturing company, Paxman Coolers, of Fenay Bridge, ... University of Huddersfield. , The research will be led ... in the pharmacology of cancer treatment, which he will ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
(Date:10/29/2014)... and environmental, have been blamed for increasing the ... as a family history of schizophrenia, are widely ... gondii , a parasite transmitted by soil, undercooked ... skepticism. , A new study by Gary Smith, ... University of Pennsylvania,s School of Veterinary Medicine, used ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Penn vet professor investigates parasite-schizophrenia connection 2Penn vet professor investigates parasite-schizophrenia connection 3
... that died 44,000 years ago in Antarctica have provided ... traditional genetic aging measurements, and suggest those approaches have ... 200 to 600 percent. In other words, a ... 100,000 years old may actually be 200,000 to 600,000 ...
... -- Agricultural soils accumulate trace metals, particularly copper ... wastes (sewage biosolids and manures) and fungicides that are ... for tolerable concentrations of these potentially plant-toxic elements in ... effects of the metals are substantially independent and not ...
... and LAS VEGAS, Nov. 9 CBS Vision, the ... Media Group company, today announced a new research partnership that will ... housed in the MGM Grand Hotel in Las Vegas. , ... one of the county,s leading agencies, will be called Communications ...
Cached Biology News:Ancient penguin DNA raises doubts about accuracy of genetic dating techniques 2Additive copper-zinc interaction affects toxic response in soybean 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4
(Date:10/30/2014)... October 29, 2014 Global polyvinyl chloride ... world economic crisis during 2008-2009, especially in North America ... and currently is keeping to a growing trend. , ... is utilized in the construction segment. In 2013, the ... profiles, tubing, sheets and rigid film. Moreover, the PVC ...
(Date:10/30/2014)... 30, 2014 James Sherley says he has ... tissue stem cell technology since his days as a principal ... in the late 1990’s. Sherley founded the ASCTC as ... holds all the intellectual property developed in Sherley’s research over ... Massachusetts Institute of Technology (MIT), and more recently as a ...
(Date:10/30/2014)... CARLSBAD, Calif. , Oct. 30, 2014 Isis ... antisense therapeutics, today announced that management will present a company ... 2014 at 8:30 a.m. ET in Boston, MA. ... will be available on the "Investors & Media" section of ... available on the Isis website within 48 hours and will ...
(Date:10/27/2014)... Ryan Carfley , Managing Partner at ... down with Bryan Hamilton, the publisher of the Triangle Business ... in the Research Triangle region of North Carolina. , Just ... the roundtable include the role of social media in ... balance and the unique role that Millennials play in the ...
Breaking Biology Technology:Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Personify's Ryan Carfley Talks Recruiting with Triangle Business Journal, RPG Solutions 2Personify's Ryan Carfley Talks Recruiting with Triangle Business Journal, RPG Solutions 3
... 2011 Bayer HealthCare,s affiliate MEDRAD, Inc. today ... demonstrated a 59 percent relative reduction in target ... patients with peripheral arterial disease (PAD) treated with ... compared to standard balloon angioplasty (POBA). Additionally, for ...
... SAN DIEGO, Nov. 10, 2011 Verenium Corporation (Nasdaq: ... focused on the development and commercialization of high-performance enzymes, ... financial results for the third quarter and nine months ... strong financial and operational progress in the first nine ...
... GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical ... Human Immunodeficiency Virus (HIV) infections, today announced its financial ... GeoVax reported a net loss of $375,852 ... 30, 2011, compared to $644,666 ($0.04 per share) for ...
Cached Biology Technology:Bayer HealthCare's Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon 2Bayer HealthCare's Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon 3Bayer HealthCare's Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon 4Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 2Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 3Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 4Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 5Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 6Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 7Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 8Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 9GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results 2GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results 3GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results 4GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results 5
... [RS17 ] to PRKAR2 cAMP is ... of cellular functions. cAMP exerts its effects ... which transduces the signal through phosphorylation of ... AMPK is a tetramer composed of two ...
... Rocking Shaker provides the exact agitation ... The very slow to fast speed ... provide a gentle wave motion that ... blotted membranes to achieve faster, more ...
...
... Have you bought a Perkin Elmer UltraVIEW ... using the Andor iXon and iQ software? No ... that upgrade. You keep your existing microscope, lasers, ... will customise it to work with our precision ...
Biology Products: